Ascletis Pharma, Inc. (ASCLF)
0.73
0.00 (0.00%)
USD |
OTCM |
Oct 26, 16:00
Ascletis Pharma Market Cap : 770.14M for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 770.14M |
| October 23, 2026 | 770.14M |
| October 22, 2026 | 770.14M |
| October 21, 2026 | 812.34M |
| October 20, 2026 | 791.24M |
| October 19, 2026 | 791.24M |
| October 16, 2026 | 791.24M |
| October 15, 2026 | 791.24M |
| October 14, 2026 | 791.24M |
| October 13, 2026 | 928.39M |
| October 12, 2026 | 928.39M |
| October 09, 2026 | 1.150B |
| October 08, 2026 | 1.150B |
| October 07, 2026 | 1.150B |
| October 06, 2026 | 1.097B |
| October 05, 2026 | 1.097B |
| October 02, 2026 | 1.097B |
| October 01, 2026 | 1.182B |
| September 30, 2026 | 1.182B |
| September 29, 2026 | 1.118B |
| September 28, 2026 | 1.266B |
| September 25, 2026 | 1.266B |
| September 24, 2026 | 1.266B |
| September 23, 2026 | 1.187B |
| September 22, 2026 | 1.187B |
| Date | Value |
|---|---|
| September 21, 2026 | 1.187B |
| September 18, 2026 | 1.088B |
| September 17, 2026 | 1.088B |
| September 16, 2026 | 1.088B |
| September 15, 2026 | 1.187B |
| September 14, 2026 | 1.187B |
| September 11, 2026 | 1.197B |
| September 10, 2026 | 1.286B |
| September 09, 2026 | 1.286B |
| September 08, 2026 | 1.286B |
| September 04, 2026 | 1.286B |
| September 03, 2026 | 1.266B |
| September 02, 2026 | 1.266B |
| September 01, 2026 | 1.266B |
| August 31, 2026 | 1.286B |
| August 28, 2026 | 1.286B |
| August 27, 2026 | 1.286B |
| August 26, 2026 | 1.286B |
| August 25, 2026 | 1.286B |
| August 24, 2026 | 1.286B |
| August 21, 2026 | 1.286B |
| August 20, 2026 | 1.286B |
| August 19, 2026 | 1.286B |
| August 18, 2026 | 1.286B |
| August 17, 2026 | 1.326B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CStone Pharmaceuticals Co. Ltd. | 1.201B |
| RemeGen Co., Ltd. | 5.586B |
| InnoCare Pharma Ltd. | 2.823B |
| Adagene, Inc. | 173.23M |
| JW (Cayman) Therapeutics Co. Ltd. | 82.08M |
Market Cap Related Metrics
| PS Ratio | 5535.65 |
| PEG Ratio | -0.0602 |
| Price to Book Value | 6.570 |
| Price | 0.73 |
| Earnings Yield | -11.49% |
| PEGY Ratio | -0.0602 |